Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients

INTRODUCTION: Eicosanoids and intracellular signaling pathways are potential targets for host-directed therapy (HDT) in tuberculosis (TB). We have explored the effect of cyclooxygenase 2 inhibitor (COX-2i) treatment on eicosanoid levels and signaling pathways in monocytes. METHODS: Peripheral blood...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Cell Infect Microbiol
Main Authors: Jøntvedt Jørgensen, Marthe, Nore, Kristin G., Aass, Hans Christian D., Layre, Emilie, Nigou, Jérôme, Mortensen, Rasmus, Tasken, Kjetil, Kvale, Dag, Jenum, Synne, Tonby, Kristian, Dyrhol-Riise, Anne Ma
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Cellular and Infection Microbiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8299478/
https://ncbi.nlm.nih.gov/pubmed/34307194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcimb.2021.669623
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados